P

PTC Therapeutics
D

PTCT

50.340
USD
-1.04
(-2.02%)
قبل الجلسة
حجم التداول
39
الربح لكل سهم
8
العائد الربحي
-
P/E
8
حجم السوق
3,989,798,336
أصول ذات صلة
BMRN
BMRN
-1.190
(-1.96%)
59.460 USD
E
ESPR
-0.12000
(-6.25%)
1.80000 USD
INCY
INCY
0.575
(0.74%)
78.230 USD
NBIX
NBIX
-2.755
(-2.15%)
125.590 USD
Q
QURE
-0.055
(-0.41%)
13.435 USD
R
RARE
-0.265
(-0.94%)
27.810 USD
REGN
REGN
5.11
(0.92%)
560.19 USD
S
SRPT
1.740
(10.71%)
17.980 USD
VRTX
VRTX
-9.99
(-2.59%)
375.66 USD
المزيد
الأخبار المقالات

العنوان: PTC Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.